PCSK9 Inhibition During the Inflammatory Stage of SARS-CoV-2 Infection:
Abstract Background The intensity of inflammation during COVID-19 is related to adverse outcomes. Proprotein convertase subtilisin/kexin type 9 (PCSK9) is involved in low-density lipoprotein recept…